Agonists at PPAR-γ suppress angiotensin II-induced production of plasminogen activator inhibitor-1 and extracellular matrix in rat cardiac fibroblasts

被引:57
作者
Hao, G-H [1 ,2 ]
Niu, X-L [1 ,2 ]
Gao, D-F [1 ]
Wei, J. [1 ]
Wang, N-P [3 ]
机构
[1] Xian Jiaotong Univ, Sch Med, Affiliated Hosp 2, Dept Cardiol, Xian 710004, Shaanxi, Peoples R China
[2] Xian Jiaotong Univ, Key Lab Environm & Genes Related Dis, Dept Cardiol, Minist Educ, Xian, Shaanxi, Peoples R China
[3] Peking Univ, Hlth Sci Ctr, Inst Cardiovasc Sci, Dept Cardiol, Beijing 100871, Peoples R China
关键词
PPAR-gamma; angiotensin; cardiac fibroblast; plasminogen activator inhibitor-1; extracellular matrix; rosiglitazone; 15d-PGJ(2); fibrosis;
D O I
10.1038/bjp.2008.21
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and purpose: Peroxisome proliferator-activated receptor (PPAR)-gamma ligands have been shown to inhibit cardiac fibrosis. However, the underlying mechanisms are poorly understood. We investigated the regulation by PPAR-gamma ligands of angiotensin (Ang) II-induced plasminogen activator inhibitor (PAI)-1, extracellular matrix (ECM) production and cell growth in cardiac fibroblasts. Experimental approach: The effects of PPAR-gamma ligands on Ang II-induced PAI-1, ECM expression and cell growth were assessed in primary-cultured rat cardiac fibroblasts; cardiac PAI-1 and ECM production was examined in Ang II-infused rats. Key results: In growth-arrested cardiac fibroblasts, PPAR-gamma ligands rosiglitazone and 15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)) dose-dependently attenuated Ang II-induced cell proliferation and expression of PAI-1, collagen type-I, collagen type-III and fibronectin. An accompanying increase in PPAR-gamma expression and activation was also observed. These suppressive effects were attenuated by the PPAR-gamma antagonists GW9662 and bisphenol A diglycidyl ether ( BADGE). Moreover, rosiglitazone and 15d-PGJ(2) inhibited in part the expression and phosphorylation of Ang II-induced transforming growth factor ( TGF)-beta 1, Smad2/3 and c-Jun NH(2)-terminal kinase (JNK). Ang II infusion in rats markedly increased left ventricular production of PAI-1, collagen and fibronectin, with a concurrent increase in the ratios of heart weight/body weight and left ventricle weight/body weight. Co-treatment with rosiglitazone significantly decreased these levels and upregulated PPAR-gamma expression. Conclusions and implications: Rosiglitazone and 15d-PGJ2 suppress Ang II-induced production of PAI-1 and ECM probably via interactions between PPAR-gamma and TGF-beta 1/Smad2/3 and JNK signalling pathways. It is suggested that PPAR-gamma and its ligands may have potential applications in preventing cardiac fibrosis.
引用
收藏
页码:1409 / 1419
页数:11
相关论文
共 52 条
[31]   Angiotensin II stimulates c-Jun NH2-terminal kinase in cultured cardiac myocytes of neonatal rats [J].
Kudoh, S ;
Komuro, I ;
Mizuno, T ;
Yamazaki, T ;
Zou, YZ ;
Shiojima, I ;
Takekoshi, N ;
Yazaki, Y .
CIRCULATION RESEARCH, 1997, 80 (01) :139-146
[32]   Peroxisome proliferator-activated receptor-γ ligands attenuate brain natriuretic peptide production and affect remodeling in cardiac fibroblasts in reoxygenation after hypoxia [J].
Makino, Naoki ;
Sugano, Masahiro ;
Satoh, Shinji ;
Oyama, Junichi ;
Maeda, Toyoki .
CELL BIOCHEMISTRY AND BIOPHYSICS, 2006, 44 (01) :65-71
[33]   Ligands of peroxisome proliferator-activated receptor-γ block activation of pancreatic stellate cells [J].
Masamune, A ;
Kikuta, K ;
Satoh, M ;
Sakai, Y ;
Satoh, A ;
Shimosegawa, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (01) :141-147
[34]   Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo [J].
Nakamura, S ;
Nakamura, I ;
Ma, LJ ;
Vaughan, DE ;
Fogo, AB .
KIDNEY INTERNATIONAL, 2000, 58 (01) :251-259
[35]   Expression and function of peroxisome proliferator-activated receptor-γ in mesangial cells [J].
Nicholas, SB ;
Kawano, Y ;
Wakino, S ;
Collins, AR ;
Hsueh, WA .
HYPERTENSION, 2001, 37 (02) :722-727
[36]  
Nissen S.E., 2007, ENGL J MED, V356, P2457
[37]   Role of c-Jun NH2-terminal kinase in G-protein-coupled receptor agonist-induced cardiac plasminogen activator inhibitor-1 expression [J].
Omura, T ;
Yoshiyama, M ;
Matsumoto, R ;
Kusuyama, T ;
Enomoto, S ;
Nishiya, D ;
Izumi, Y ;
Kim, S ;
Ichijo, H ;
Motojima, M ;
Akioka, K ;
Iwao, H ;
Takeuchi, K ;
Yoshikawa, J .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2005, 38 (04) :583-592
[38]   PPARγ agonists exert antifibrotic effects in renal tubular cells exposed to high glucose [J].
Panchapakesan, U ;
Sumual, S ;
Pollock, CA ;
Chen, X .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2005, 289 (05) :F1153-F1158
[39]   Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-γ [J].
Park, KS ;
Ciaraldi, TP ;
Lindgren, K ;
Abrams-Carter, L ;
Mudaliar, S ;
Nikoulina, SE ;
Tufari, SR ;
Veerkamp, JH ;
Vidal-Puig, A ;
Henry, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (08) :2830-2835
[40]   Troglitazone inhibits synthesis of transforming growth factor-β1 and reduces matrix production in human peritoneal mesothelial cells [J].
Peng, Youming ;
Liu, Hong ;
Liu, Fuyou ;
Liu, Yinghong ;
Li, Jun ;
Chen, Xing .
NEPHROLOGY, 2006, 11 (06) :516-523